...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Endovascular repair in traumatic thoracic aortic injuries: comparison with open surgical repair.
【24h】

Endovascular repair in traumatic thoracic aortic injuries: comparison with open surgical repair.

机译:胸主动脉外伤的血管内修复:与开放性手术修复的比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: Thoracic endovascular aortic repair (TEVAR) has emerged as an alternative to open surgical repair (OSR) of traumatic thoracic aortic injury (TTAI). Herein immediate and midterm outcomes of TEVAR are compared with those of OSR. MATERIALS AND METHODS: Health records were used to identify patients with TTAI presenting between April 1995 and September 2006. Preoperative patient characteristics, intraoperative variables, procedural costs, and outcomes were recorded. RESULTS: A total of 103 patients were identified. Twenty-two died before treatment, 19 were treated conservatively, 36 received OSR, and 26 received TEVAR. In the OSR group, time from diagnosis to treatment was 8 hours, the 30-day mortality rate was 11.1%, and all deaths occurred intraoperatively. Thoracic nerve injury occurred in four patients (12.5%), pneumonia in 12 (37.5%), temporary renal failure in one (3%), paraparesis in three (9.4%), and paraplegia in five (15.6%). On follow-up (mean, 61 months), postthoracotomy pleural reaction was seen in three cases (9.4%). In the TEVAR group, time to treatment was 38 hours (P < .01) and the 30-day mortality rate was 7.4% with no intraoperative deaths. Pneumonia was seen in two cases (8.3%) and left arm ischemia was seen in two of 17 patients in whom the left subclavian artery was covered. On midterm follow-up (mean, 17 months), there were no graft failures or repeat aortic interventions. Costs of each procedure were initially comparable, but follow-up expenses with TEVAR were Dollars 1,284 (Canadian) greater per year. CONCLUSIONS: TEVAR of TTAI is associated with lower perioperative mortality and morbidity rates than OSR, with no significant graft-related complications on midterm follow-up. The study data support the continued use of TEVAR in this context.
机译:目的:胸腔内血管主动脉修复术(TEVAR)已经成为创伤性胸主动脉损伤(TTAI)的开放手术修复(OSR)的替代方法。在此,将TEVAR的近期和中期结果与OSR的结果进行比较。材料与方法:使用健康记录来识别1995年4月至2006年9月期间出现的TTAI患者。术前记录患者的特征,术中变量,手术费用和结局。结果:共鉴定出103例患者。治疗前有22例死亡,保守治疗19例,OSR治疗36例,TEVAR治疗26例。 OSR组从诊断到治疗的时间为8小时,30天的死亡率为11.1%,所有死亡均发生在术中。胸神经损伤发生在4例患者中(12.5%),肺炎发生在12例中(37.5%),暂时性肾衰竭1例(3%),轻瘫(3例)(9.4%),截瘫5例(15.6%)。随访(平均61个月),开胸术后出现胸膜反应3例(9.4%)。 TEVAR组的治疗时间为38小时(P <.01),30天死亡率为7.4%,无术中死亡。 17例患者中有2例出现肺炎(8.3%),左锁骨下动脉被覆盖的患者中有2例出现左臂缺血。在中期随访(平均17个月)时,未发生移植失败或重复主动脉干预。最初每个程序的费用是可比较的,但是TEVAR的后续费用每年增加1,284美元(加拿大)。结论:TTAI的TEVAR与OSR相比,围手术期死亡率和发病率较低,中期随访无明显的移植相关并发症。研究数据支持在这种情况下继续使用TEVAR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号